About this trial
Blocking histamine H1/H2 receptors blunts chronic endurance training adaptations. The current study addresses the following research question: "What is the influence of histamine H1 signaling on training adaptations following ten weeks of resistance training in human skeletal muscle." Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male
18-45 years
Not to medium physically active
Disqualifiers
Smoking
Chronic disease
High blood pressure
Supplement or medication intake
Trial design
Parallel
Treatments tested in this trial
Placebo
DrugOral placebo
H1 blockade: Telfast: 180mg Fexofenadine
DrugH1 blockade: oral blockade with 180mg Fexofenadine
Resistance training
BehavioralResistance training: lower body exercise
Treatment groups
Trial outcomes
Primary outcomes
Muscle volume
Change in muscle volume
Maximal dynamic strength of leg press, bench press, bicep curl and leg curl
Change in maximal dynamic strength of leg press, bench press, bicep curl and leg curl
Muscle fiber hypertrophy in muscle biopsies
Change in muscle fiber hypertrophy in muscle biopsies
Matsuda index, to estimate whole body glucose metabolism, will be calculated using an oral glucose tolerance test (OGTT: concentration of glucose and insulin in the blood will be measured before and after drinking 75g glucose)
Change in Matsuda index, to estimate whole body glucose metabolism, will be calculated using an oral glucose tolerance test (OGTT: concentration of glucose and insulin in the blood will be measured before and after drinking 75g glucose)
Secondary outcomes
Blood pressure (systolic and diastolic)
Chance in Blood pressure (systolic and diastolic)
Resting heart rate
Chance in Resting heart rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Ghent
Lead sponsor
Research Foundation Flanders
Collaborator